Literature DB >> 21036599

Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies.

Ewout F W Courrech Staal1, Vincent T H B M Smit, Marie-Louise F van Velthuysen, Juliette M J Spitzer-Naaykens, Michel W J M Wouters, Wilma E Mesker, Rob A E M Tollenaar, Johanna W van Sandick.   

Abstract

BACKGROUND: Tumour stroma ratio (TSR) in histological sections of resected oesophageal adenocarcinomas proved to be a prognostic factor for patients' survival. The objectives of this study were to assess inter- and intraobserver agreement for TSR scoring on biopsy material and to validate these biopsy results with the results derived from surgical specimens.
METHODS: Biopsies and surgical specimens of 91 patients with oesophageal adenocarcinoma were available. TSR was determined on the original haematoxylin-eosin (H&E) tissue sections from primary tumour biopsies. To assess interobserver variation, TSR was scored by three pathologists as 0-25%, 25-50%, 50-75% or 75-100%. A second scoring was done to examine intraobserver variation. The definitive TSR biopsy score was compared with the corresponding resection specimen score. Kappa statistics were applied to evaluate agreement.
RESULTS: Biopsies of 10 (11%) patients were rejected because of poor quality. For 81 TSR biopsy scores, interobserver correlations ranged between 0.239 and 0.486 (P < 0.001 for all). By classifying scores into two groups (<50% and ≥ 50%), interobserver correlations ranged between 0.372 and 0.886 (P < 0.001 for all). Intraobserver agreement was substantial to near-perfect (κ = 0.780-0.848; P < 0.001 for all). Definitive TSR biopsy score showed moderate correlation with TSR scores on surgical specimens (κ = 0.506), but it was an independent prognostic factor for survival.
CONCLUSION: Reproducibility of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies was good. The ease of TSR scoring on H&amp;E sections together with its correlation with patients' survival may have clinical relevance in this era of neoadjuvant therapy.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21036599     DOI: 10.1016/j.ejca.2010.09.043

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  24 in total

1.  Is tumor cellularity in primary invasive breast carcinoma of prognostic significance?

Authors:  Emily S Reisenbichler; William Dupont; W Dale Plummer; Omar Hameed
Journal:  Virchows Arch       Date:  2017-04-19       Impact factor: 4.064

2.  Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial.

Authors:  T J A Dekker; A Charehbili; V T H B M Smit; P ten Dijke; E Meershoek-Klein Kranenbarg; C J H van de Velde; J W R Nortier; R A E M Tollenaar; W E Mesker; J R Kroep
Journal:  Mol Oncol       Date:  2015-02-14       Impact factor: 6.603

Review 3.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

Review 4.  Standardization of the tumor-stroma ratio scoring method for breast cancer research.

Authors:  Sophie C Hagenaars; Kiki M H Vangangelt; Gabi W Van Pelt; Zsófia Karancsi; Rob A E M Tollenaar; Andrew R Green; Emad A Rakha; Janina Kulka; Wilma E Mesker
Journal:  Breast Cancer Res Treat       Date:  2022-04-16       Impact factor: 4.624

Review 5.  Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.

Authors:  L H McCormick Matthews; F Noble; J Tod; E Jaynes; S Harris; J N Primrose; C Ottensmeier; G J Thomas; T J Underwood
Journal:  Br J Cancer       Date:  2015-06-25       Impact factor: 7.640

6.  Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.

Authors:  W E Mesker; T J A Dekker; E M de Kruijf; C C Engels; G W van Pelt; V T H B M Smit; R A E M Tollenaar
Journal:  Br J Cancer       Date:  2014-11-13       Impact factor: 7.640

7.  Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.

Authors:  Timothy J Underwood; Annette L Hayden; Mathieu Derouet; Edwin Garcia; Fergus Noble; Michael J White; Steve Thirdborough; Abbie Mead; Nicholas Clemons; Massimiliano Mellone; Chudy Uzoho; John N Primrose; Jeremy P Blaydes; Gareth J Thomas
Journal:  J Pathol       Date:  2015-02       Impact factor: 7.996

8.  Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'.

Authors:  C L Downey; S A Simpkins; D L Holliday; J L Jones; L B Jordan; J Kulka; A M Hanby; V Speirs
Journal:  Br J Cancer       Date:  2014-11-13       Impact factor: 7.640

9.  Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study.

Authors:  René Scheer; Alexi Baidoshvili; Shorena Zoidze; Marloes A G Elferink; Annefleur E M Berkel; Joost M Klaase; Paul J van Diest
Journal:  World J Gastrointest Oncol       Date:  2017-12-15

10.  Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic Tool.

Authors:  R Rogojanu; T Thalhammer; U Thiem; A Heindl; I Mesteri; A Seewald; W Jäger; C Smochina; I Ellinger; G Bises
Journal:  Biomed Res Int       Date:  2015-10-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.